Low-density lipoprotein cholesterol versus particle number in middle school children
- PMID: 23415622
- PMCID: PMC3659184
- DOI: 10.1016/j.jpeds.2013.01.012
Low-density lipoprotein cholesterol versus particle number in middle school children
Abstract
Objectives: To characterize lipids and lipoproteins in a diverse school-based cohort and identify features associated with discordance between low-density lipoprotein cholesterol (LDL-C) and LDL particle (LDL-P).
Study design: Sixth-grade children enrolled in the HEALTHY trial (n = 2384; mean age 11.3 ± 0.6 years; 54.2% female) were evaluated for standard lipids, lipoprotein particles measured by nuclear magnetic resonance, and homeostatic model of insulin resistance. Characteristics of subgroups with values of LDL-C and LDL-P discordant by >20 percentile units, an amount reasoned to be clinically significant, were compared.
Results: Four-hundred twenty-eight (18%) of children were in the LDL-P < LDL-C subgroup and 375 (16%) in the LDL-P > LDL-C subgroup. Those with LDL-P > LDL-C had significantly greater body mass index, waist circumference, homeostatic model of insulin resistance, triglycerides, systolic and diastolic blood pressure, and reflected a greater Hispanic ethnic composition but fewer of black race than both the concordant (LDL-P ≅ LDL-C) and opposite discordant (LDL-P < LDL-C) subgroups.
Conclusions: There is as much lipoprotein cholesterol compositional heterogeneity in sixth graders as has been described in adults and a discordant atherogenic phenotype of LDL-P > LDL-C, common in obesity, is often missed when only LDL-C is considered. Conversely, many children with moderate-risk cholesterol measures (75th to 99th percentile) have a lower LDL-P burden.
Trial registration: ClinicalTrials.gov NCT00458029.
Keywords: Apolipoprotein B; BMI; Body mass index; CVD; Cardiovascular disease; HDL-C; HDL-P; HOMA-IR; High-density lipoprotein cholesterol; High-density lipoprotein particle; Homeostatic model of insulin resistance; LDL; LDL-C; LDL-P; Low-density lipoprotein; Low-density lipoprotein cholesterol; Low-density lipoprotein particle; NMR; Nuclear magnetic resonance; TC; TG; Total cholesterol; Triglycerides; VLDL; VLDL-P; Very-low-density lipoprotein; Very-low-density lipoprotein particle; apoB.
Copyright © 2013 Mosby, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008 Apr 15;51:1512–1524. - PubMed
-
- Kavey R-E, Simons-Morton DG, DeJesus JM. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Healthy and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213–S256. - PMC - PubMed
-
- Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007 Aug 7;116:664–668. - PubMed
-
- Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Despres JP, Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol. 2003 May 15;91:1173–1177. - PubMed
-
- Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol. 2005 Oct 4;46:1225–1228. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
